Floatz logo

CAFFEINE

BCLC Stage C HCC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Small moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the BCLC Stage C HCC cohort.

Asset / SponsorPhaseRating
WARFARIN
Mansoura University
Phase 4BB
METOPROLOL
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2CCC
Omeprazole
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2CCC
MIDAZOLAM
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2CCC

Same molecule, other indications

CAFFEINE is also rated in:

migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
Carcinoma, Renal CellDormant
BB
Indicative ·
70 / 100
View asset →
renal cell carcinomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →